Agenus Inc
AGENNasdaqCIK 1098972HealthcareFiscal year ends Dec 31
Reports and events: 396 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1820:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001193125-26-355559 |
| 2026-08-1301:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-347518 |
| 2026-08-1120:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-344783 |
| 2026-08-0720:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-340363 |
| 2026-08-0611:52 ET | 8-K | 2.02 Results of operations | 0001193125-26-336780 |
| 2026-07-1310:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-301414 |
| 2026-07-0620:10 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-296186 |
| 2026-06-2314:14 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-278647 |
| 2026-05-1520:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-226693 |
| 2026-05-1121:04 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-217082 |
| 2026-05-1112:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-215838 |
| 2026-04-3020:34 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001193125-26-197536 |
| 2026-03-2612:24 ET | 8-K | 8.01 Other events | 0001193125-26-125170 |
| 2026-03-1621:19 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-108632 |
| 2026-03-1612:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-107288 |
| 2026-01-2313:57 ET | SCHEDULE 13D | Ownership report, active investor | 0002106704-26-000001 |
| 2026-01-1613:25 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-014678 |
| 2026-01-1421:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-012922 |
| 2026-01-0821:13 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights | 0001193125-26-007706 |
| 2025-11-1022:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-274554 |
| 2025-11-1012:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-273266 |
| 2025-10-0920:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-25-235819 |
| 2025-09-2321:12 ET | 8-K | 8.01 Other events | 0001193125-25-213574 |
| 2025-08-1120:55 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106633 |
| 2025-08-1111:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106235 |
| 2025-06-2020:10 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-088502 |
| 2025-06-0420:37 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-081674 |
| 2025-05-1220:50 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069396 |
| 2025-05-1211:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-068564 |
| 2025-04-3020:05 ET | DEF 14A | Proxy statementPeriod 2025-04-30 | 0000950170-25-061030 |
| 2025-03-1720:16 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-040289 |
| 2025-03-1111:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036829 |
| 2025-02-2622:21 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-027947 |
| 2025-02-1021:05 ET | 8-K | 1.02 Termination of a material agreement | 0000950170-25-017028 |
| 2024-12-0512:35 ET | 8-K | 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000950170-24-133532 |
| 2024-11-2713:39 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-131263 |
| 2024-11-1221:58 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125608 |
| 2024-11-1212:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124543 |
| 2024-11-0821:05 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0000950170-24-124055 |
| 2024-11-0521:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-121443 |
| 2024-08-0820:49 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-197046 |
| 2024-08-0820:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093937 |
| 2024-08-0220:02 ET | 8-K | 1.02 Termination of a material agreement | 0000950170-24-089932 |
| 2024-06-1720:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-074231 |
| 2024-06-1420:02 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-073614 |
| 2024-05-3020:01 ET | 8-K | 2.01 Completion of an acquisition or disposition | 0000950170-24-066545 |
| 2024-05-0711:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053952 |
| 2024-05-0711:38 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-053951 |
| 2024-05-0711:31 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-053949 |
| 2024-04-2616:28 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0000950170-24-048786 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.